(S)-1-Hydroxy­propan-2-aminium (2R,3R)-3-carb­oxy-2,3-dihydroxy­propanoate monohydrate

The chiral title compound, C4H10NO+·C4H5O6 −·H2O, is a hydrated mol­ecular salt in which the tartaric acid has transferred one proton to the (S)-2-amino­propan-1-ol mol­ecule. The crystal structure is stabilized by a three-dimensional network of N—H⋯O and O—H⋯O hydrogen bonds. The absolute configuration was assigned on the basis of the starting materials

Digital Tools for Revealing and Reducing Carbon Footprint in Infrastructure, Building, and City Scopes

The climate change issue has been striking and bringing pressure on all countries and industries. The responsibility of the Architecture, Engineering, Construction and Facility Management (AEC/FM) industry is heavy because it accounts for over one-third of global energy use and greenhouse gas emissions. At the same time, the development of digital technology brings the opportunity to mitigate environmental issues. Therefore, this study intended to examine the state-of-the-art of digital development and transformation in the AEC/FM industry by collecting and reviewing the developed digital carbon footprint analysis tools in infrastructure, building, and city scopes. Specifically, this study (1) generated a review methodology for carbon footprint analysis results; (2) demonstrated the review results from the infrastructure, building, and city scopes, analysed and compared the results crossing the scopes from four aspects: carbon footprint analysis strategy, standards and protocols, rating systems, and general development level of digital tools; and (3) discussed the potential directions in the industry to address the environmental issues. This study indicated that the digitalisation level regarding carbon-related areas is still at an early stage, and efforts should be taken both academically and practically to drive the digital development confronting the harsh climate change issue

Green synthesis of CuO nanoparticles using Cassia auriculata leaf extract and in vitro evaluation of their biocompatibility with rheumatoid arthritis macrophages (RAW 264.7)

Purpose: To undertake green synthesis of copper oxide nanoparticles (CuO NPs) using Cassia auriculata leaf extract and evaluate their biocompatibility with rheumatoid arthritis macrophages (RAW 264.7 cell line).Methods: CuO NPs were prepared by heating a mixture of 10 mL of 0.01 M CuSO4 solution and 30 mL of C. auriculata extract at 80 °C for 1 h. The synthesized CuO NPs were characterized by x-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), ultraviolet-visible spectroscopy (UVVis), energy-dispersive x-ray spectroscopy (EDS), scanning electron microscopy (SEM), transmission electron microscopy (TEM) and dynamic light scattering (DLS). The cytotoxicity of the NPs against RAW 264.7 cells was studied using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.Results: The gradual change in color of the reaction solution from brownish yellow to dark brown indicated CuO NP formation. TEM images revealed spherical, polydispersed NPs (mean particle size, 23 nm). FTIR results indicated capping of polyphenols on the surface of the NPs. Most RAW 264.7 cells (> 95 %) remained alive following exposure to CuO NPs at concentrations of up to 200 μg/mL, indicating biocompatible with the cells.Conclusion: An eco-friendly, low-cost, biosynthetic method for CuO NP preparation has been successfully developed using C. auriculata leaf extract. Furthermore, the nanoparticles are biocompatible with RAW 264.7 cell line.Keywords: Cassia auriculata extract, Copper oxide nanoparticles, RAW 264.7 cell line, Rheumatoid arthriti

Increased Methylation of the MOR Gene Proximal Promoter in Primary Sensory Neurons Plays a Crucial Role in the Decreased Analgesic Effect of Opioids in Neuropathic Pain

BACKGROUND: The analgesic potency of opioids is reduced in neuropathic pain. However, the molecular mechanism is not well understood. RESULTS: The present study demonstrated that increased methylation of the Mu opioid receptor (MOR) gene proximal promoter (PP) in dorsal root ganglion (DRG) plays a crucial role in the decreased morphine analgesia. Subcutaneous (s.c.), intrathecal (i.t.) and intraplantar (i.pl.), not intracerebroventricular (i.c.v.) injection of morphine, the potency of morphine analgesia was significantly reduced in nerve-injured mice compared with control sham-operated mice. After peripheral nerve injury, we observed a decreased expression of MOR protein and mRNA, accompanied by an increased methylation status of MOR gene PP, in DRG. However, peripheral nerve injury could not induce a decreased expression of MOR mRNA in the spinal cord. Treatment with 5-aza-2′-deoxycytidine (5-aza-dC), inhibited the increased methylation of MOR gene PP and prevented the decreased expression of MOR in DRG, thereby improved systemic, spinal and periphery morphine analgesia. CONCLUSIONS: Altogether, our results demonstrate that increased methylation of the MOR gene PP in DRG is required for the decreased morphine analgesia in neuropathic pain